Showing results (1-10 of 225) with videos related to
Sort By:
Pageof 23
Cardiovascular Drugs and Therapy|July 28, 2011
C-reactive protein, statins and the risk of vascular events: a better understandingBehnood BikdeliThrombosis and Haemostasis|March 6, 2026
DOACs for Superficial Vein Thrombosis: Risks of Pooling RCTs and Observational Studies in Comparative EffectivenessBehnood BikdeliThrombosis and Haemostasis|November 18, 2024
Direct Oral Anticoagulants: Quick Primer on When to Use and When to AvoidAntoine Bejjani, Behnood BikdeliSeminars in Thrombosis and Hemostasis|March 17, 2012
Prophylaxis for venous thromboembolism: a great global divide between expert guidelines and clinical practice?Behnood Bikdeli, Babak Sharif-KashaniInterventional Cardiology Clinics|September 8, 2024
Anticoagulant Therapy in Patients Undergoing Acute Pulmonary Embolism InterventionsÁlvaro Dubois-Silva, Behnood BikdeliAnnals of Internal Medicine|January 31, 2022
In high-risk inpatients with COVID-19, therapeutic- vs. standard-dose heparin reduced thromboembolism or death at 30 dBehnood Bikdeli, David A GarciaAnnals of Internal Medicine|January 31, 2022
In patients hospitalized with COVID-19, therapeutic- vs. prophylactic-dose heparin did not reduce a composite outcome at 28 dBehnood Bikdeli, David A GarciaCurrent Opinion in Pulmonary Medicine|October 29, 2024
Pulmonary embolism work-up in chronic obstructive pulmonary disease exacerbations: what is the best strategy for clinicians?David Jiménez, Laurent Bertoletti, Behnood BikdeliBMJ Case Reports|December 2, 2017
Systemic thrombolysis in a patient with massive pulmonary embolism and recent glioblastoma multiforme resectionJoshua Lampert, Behnood Bikdeli, Philip Green, et al.Clinics in Chest Medicine|August 21, 2018
Aggressive Treatment of Intermediate-Risk Patients with Acute Symptomatic Pulmonary EmbolismDavid Jimenez, Behnood Bikdeli, Peter S Marshall, et al.Pageof 23